标题
Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411
作者
关键词
-
出版物
ANTIVIRAL RESEARCH
Volume 219, Issue -, Pages 105731
出版商
Elsevier BV
发表日期
2023-10-12
DOI
10.1016/j.antiviral.2023.105731
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study
- (2023) Jiao Liu et al. The Lancet Regional Health Western Pacific
- Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2
- (2022) Bo Hou et al. JOURNAL OF NATURAL PRODUCTS
- Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features
- (2022) Foad Rommasi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development
- (2022) Zongyang Lv et al. Frontiers in Chemistry
- Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
- (2022) Baoqi Zeng et al. BMC Medicine
- Marine Natural Products as Leads against SARS-CoV-2 Infection
- (2022) Bhuwan Khatri Chhetri et al. JOURNAL OF NATURAL PRODUCTS
- A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic
- (2022) Tirosh Shapira et al. NATURE
- Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants
- (2022) Clauber Henrique Souza da Costa et al. Scientific Reports
- Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance
- (2022) Lirong Cao et al. NATURE MEDICINE
- Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity
- (2022) Ashley Jia Wen Yip et al. Viruses-Basel
- Identification of Cyanobacteria-Based Natural Inhibitors Against SARS-CoV-2 Druggable Target ACE2 Using Molecular Docking Study, ADME and Toxicity Analysis
- (2022) Niharika Sahu et al. Indian Journal of Clinical Biochemistry
- Role of natural products towards the SARS-CoV-2: A critical review
- (2022) Kannan Raman et al. Annals of Medicine and Surgery
- Bioactive natural products in COVID-19 therapy
- (2022) Zhonglei Wang et al. Frontiers in Pharmacology
- Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics
- (2022) Jimena Pérez-Vargas et al. ANTIVIRAL RESEARCH
- Mutations in SARS-CoV-2 structural proteins: a global analysis
- (2022) Mohammad Abavisani et al. Virology Journal
- CyanoMetDB, a comprehensive public database of secondary metabolites from cyanobacteria
- (2021) Martin R. Jones et al. WATER RESEARCH
- POKY: a software suite for multidimensional NMR and 3D structure calculation of biomolecules
- (2021) Woonghee Lee et al. BIOINFORMATICS
- Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2
- (2021) Léna Petit et al. JOURNAL OF APPLIED PHYCOLOGY
- Precision therapeutic targets for COVID-19
- (2021) Zachary A. Krumm et al. Virology Journal
- SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery
- (2021) Apoorva Mulay et al. Cell Reports
- Antiviral Cyanometabolites—A Review
- (2021) Hanna Mazur-Marzec et al. Biomolecules
- Recent advances in developing small-molecule inhibitors against SARS-CoV-2
- (2021) Rong Xiang et al. Acta Pharmaceutica Sinica B
- Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L
- (2021) Anneliese S. Ashhurst et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Cellular Factors Required for SARS-CoV-2 Replication
- (2021) Aleksandra Synowiec et al. Cells
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis
- (2020) Devashan Naidoo et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Peptide and peptide-based inhibitors of SARS-CoV-2 entry
- (2020) Desiree Schütz et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
- (2020) Hongpeng Jia et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- In vitro assessment of dual (antiviral and antitumor) activity of a novel lectin produced by the newly cyanobacterium isolate, Oscillatoria acuminate MHM-632 MK014210.1
- (2020) Mabroka H. Saad et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV
- (2020) Aleksandra Milewska et al. JOURNAL OF VIROLOGY
- Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1
- (2020) Aleksandra Milewska et al. Science Signaling
- Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium Nostoc edaphicum CCNP1411
- (2018) Hanna Mazur-Marzec et al. Marine Drugs
- Calcium spirulan derived from Spirulina platensis inhibits herpes simplex virus 1 attachment to human keratinocytes and protects against herpes labialis
- (2016) Julia Mader et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Multiple Toxin Production in the CyanobacteriumMicrocystis: Isolation of the Toxic Protease Inhibitor Cyanopeptolin 1020
- (2010) Karl Gademann et al. JOURNAL OF NATURAL PRODUCTS
- Multivalent interactions with gp120 are required for the anti-HIV activity of Cyanovirin
- (2009) Yinan Liu et al. BIOPOLYMERS
- Protease Inhibitors from a Water Bloom of the CyanobacteriumMicrocystis aeruginosa
- (2009) Shiri Gesner-Apter et al. JOURNAL OF NATURAL PRODUCTS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started